A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis Multifocal IOL 1-Piece Models in Bilateral Cataract Extraction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-31

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the uncorrected binocular distance, intermediate, and near visual acuities, and assess patient's spectacle independence and satisfaction in individuals undergoing bilateral cataract extraction that have received two different arms of near add design IOLs of the same diffractive multifocal model.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Investigation of Expanded Designs of a Multifocal IOL

NCT01714635

Cataract

COMPLETED PHASE1

Evaluation the TECNIS IOL in Both Eyes VS the ReZoom IOL in One and TECNIS IOL in the Opposite

NCT01253239

Cataract

COMPLETED

Evaluation of the Tecnis™ Multifocal and Crystalens™ Accommodating Intraocular Lenses

NCT01061281

Aphakia

COMPLETED PHASE4

Clinical Investigation of the Next-Generation Intraocular Lenses

NCT03372434

Cataract

COMPLETED NA

Clinical Investigation of a New Intraocular Lens

NCT02203721

Cataract

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a multi-center, parallel comparison clinical study design with two treatment groups. One hundred (100) qualified study patients will receive a +2.75D (ZKB00) Tecnis Multifocal 1-Piece IOL in their dominant eye. Of these study patients, 50 patients will receive the +3.25D (ZLB00) Tecnis Multifocal 1-Piece IOL in their non-dominant eye and the other 50 patients will receive the +4.00D (ZMB00) Tecnis Multifocal 1-Piece IOL in their non-dominant eye. each study patient will undergo the same routine cataract extraction procedures for each eye, with the second eye scheduled to undergo cataract extraction within 7 to 30 days after the first eye. In addition, as is customary for the surgeon, each study patient will receive the same open-label pre-operative, operative and post-operative medications over the course of the study period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group 1

50 qualified study patients will receive the +2.75D (ZKB00) in their dominant eye and the +3.25D (ZLB00) in their non-dominant eye.

Group Type ACTIVE_COMPARATOR

Tecnis Multifocal 1-Piece IOL

Intervention Type DEVICE

+2.75D (ZKB00), +3.25D (ZKB00), +4.00D (ZMB00)

Treatment Group 2

50 qualified study patients will receive the +2.75D (ZKB00) in their dominant eye and the +4.00D (ZMB00) in their non-dominant eye.

Group Type ACTIVE_COMPARATOR

Tecnis Multifocal 1-Piece IOL

Intervention Type DEVICE

+2.75D (ZKB00), +3.25D (ZKB00), +4.00D (ZMB00)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tecnis Multifocal 1-Piece IOL

+2.75D (ZKB00), +3.25D (ZKB00), +4.00D (ZMB00)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A patient with bilateral cataracts for which phacoemulsification extraction and a posterior multifocal IOL implantation has been planned for both eyes.
* Male or female in good general health, 21 years of age or older at the time of the pre-operative examination and willing to have surgery on their second eye within 7 to 30 days of their first eye.
* A patient must be willing to comply with study instructions, agree to make all office appointments, and complete the entire course of the study.
* A patient has the visual potential of 20/32 or better in each eye after cataract removal and IOL implantation in the judgment of the investigator.
* A patient with a preoperative corneal astigmatism of ≤ 1.5D in each eye \[intraoperative management of corneal astigmatism is permissible, and may include arcuate incision(s) or LRI(s).\]
* A patient has a post-operative astigmatism target of ≤ 0.5D in each eye.
* A patient with clear ocular media other than cataract in each eye.
* A patient with normal OCT of the macula in each eye or a macula judged to be normal by the investigator by clinical examination.
* A patient with naturally dilated pupil sizes of \> 3.5mm, evaluated under mesopic illumination.
* A patient must be able to read, comprehend and be willing to give HIPAA and Informed Consent.

Exclusion Criteria

* A patient with a known pathology that may affect visual acuity (as determined by the investigator); particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.) in either eye.
* A patient with amblyopia or strabismus.
* A patient with capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome) in either eye.
* A patient with pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils, or pupils that do not dilate as least 3.5mm under mesopic/scotopic conditions) in either eye.
* A patient with evidence of Epithelial Basement Membrane Dystrophy on slit-lamp examination in either eye.
* A patient with evidence of keratoconus or significant irregular astigmatism on pre-operative topography in either eye.
* A patient with a history of ocular trauma, or ocular surgery in either eye.
* A patient that may, or is expected to undergo surgical intervention and/or ocular laser treatment prior to or during the study period in either eye.
* A patient that had refractive surgery (LASIK, LASEK, RK, PRK, etc.) prior to cataract surgery in either eye.
* A patient with a history of wearing PMMA lenses within 6 months, gas permeable lenses within one month, or extended wear daily soft contact lenses within seven days of their scheduled surgery.
* A patient that requires the use of systemic or ocular medications that may affect vision.
* A patient with an uncontrolled acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes, immunocompromised, etc.).
* A patient with any uncontrolled systemic disease. A potential patient in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study.
* A patient currently participating or who has participated within 30 days prior to the start of this study in a drug or other investigational research study.

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes